MARSAM PHARMS LLC
GenericsMARSAM PHARMS LLC is a generic drug manufacturer focused on Cardiovascular, Dermatology.
MARSAM PHARMS LLC's Key Drugs
MARSAM PHARMS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
MARSAM PHARMS LLC's Recent FDA Approvals
MARSAM PHARMS LLC secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.
MARSAM PHARMS LLC's Therapeutic Areas
MARSAM PHARMS LLC's approved drugs and pipeline span 2 therapeutic areas, led by Cardiovascular and Dermatology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
MARSAM PHARMS LLC's Top Competitors
MARSAM PHARMS LLC's closest competitors by therapeutic-area and drug-target overlap include Baxter, Bayer, and B BRAUN. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
MARSAM PHARMS LLC Pipeline Snapshot
Active clinical trials for MARSAM PHARMS LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1987-10-13
- Latest
- 1998-02-23
- Applications
- 19